Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00176462 · ClinicalTrials.gov registry record · Phase 2
CINJALL: Treatment for Children With Acute Lymphocytic Leukemia
A Phase 2 study, sponsored by Rutgers, The State University of New Jersey.
- Completed
- Registry status
- Phase 2
- Development phase
- 60
- Enrollment target
NCT00176462: Completed Phase 2 study, sponsored by Rutgers, The State University of New Jersey.
NCT00176462 is a Phase 2 study that has completed, run by Rutgers, The State University of New Jersey. The registered enrollment target is 60 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (55% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00176462, a Phase 2 study, has completed, sponsored by Rutgers, The State University of New Jersey.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 60 participants
- Enrollment target
Study Summary
The purpose of this research study is to identify better ways to treat children and young adults with acute lymphocytic leukemia (ALL). At the same time, doctors hope to define methods to identify those patients at higher risk for certain side effects, as well as those who are at higher risk for relapse of their leukemia.
Primary Outcome
This measure looks at the percentage of patients on Arm 2 who did not experience a relapse at 5 years, where relapse is defined as the presence of progressive disease after the achievement of a complete remission.
Interventions
- DRUG cyclophosphamide
- DRUG cytarabine
- DRUG L-asparaginase
- DRUG aminopterin
- DRUG daunomycin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2001-02 |
| Est. Completion | 2008-09 |
| Phase | Phase 2 |
What the finished NCT00176462 record still lists
NCT00176462 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (55% lower).
The record links to 0 conditions, and to 5 interventions - of which cyclophosphamide is the first listed.
NCT00176462 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00176462 about?
NCT00176462 is a clinical study titled "CINJALL: Treatment for Children With Acute Lymphocytic Leukemia". The purpose of this research study is to identify better ways to treat children and young adults with acute lymphocytic leukemia (ALL). At the same time, doctors hope to define methods to identify those patients at higher risk for certain side effects, as well as those who are at higher risk for rel...
What is the current status of trial NCT00176462?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 60 participants. The study started on 2001-02. Estimated completion is 2008-09.
What interventions are being tested in trial NCT00176462?
The interventions under investigation include: cyclophosphamide (DRUG), cytarabine (DRUG), L-asparaginase (DRUG), aminopterin (DRUG), daunomycin (DRUG).
Who is sponsoring clinical trial NCT00176462?
This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00176462's enrollment target sits among peer trials
60 1027th of 2000 higher than 868 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia